Natalie Callander
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma (NCT07479979) | Natalie Callander | 2026-07-01 |
Track Natalie Callander automatically
Every clearance here is in the API, with alerts when new ones post.